NCT00313573

Brief Summary

RATIONALE: Telemedicine may help in the treatment of depression and/or pain caused by cancer. It is not yet known whether telemedicine is more effective than standard care in treating depression and/or pain caused by cancer. PURPOSE: This phase III randomized clinical trial is studying telemedicine to see how well it works compared to standard care in treating patients with depression and/or pain caused by cancer.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for phase_3 depression

Geographic Reach
1 country

17 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 12, 2006

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
Last Updated

September 20, 2013

Status Verified

May 1, 2009

Enrollment Period

3.9 years

First QC Date

April 11, 2006

Last Update Submit

September 19, 2013

Conditions

Keywords

unspecified adult solid tumor, protocol specificpaindepression

Outcome Measures

Primary Outcomes (1)

  • Compare efficacy of 3-component model telemedicine intervention to standard care in terms of depression and pain at baseline and 1, 3, 6, and 12 months

Secondary Outcomes (3)

  • Health-related quality of life at baseline and 1, 3, 6, and 12 months

  • Cost-effectiveness of care at baseline and 1, 3, 6, and 12 months

  • Treatment satisfaction at baseline and 1, 3, 6, and 12 months

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Diagnosis of cancer AND 1 or both of the following: * Clinical depression * Depression must be of at least moderate severity (PHQ-9 score ≥ 10) * Depressed mood and/or anhedonia endorsed * No depression directly precipitated by cancer therapy for which depression is a well known side effect (e.g., interferon, corticosteroids) * Cancer-related pain * Pain must be at least moderate in severity (Brief Pain Inventory score ≥ 6), persisted despite using ≥ 2 analgesics, and cancer-related * If the only pain is due to a pre-existing condition (e.g., migraine, headache, arthritis, etc), the patient may not be eligible PATIENT CHARACTERISTICS: * Life expectancy ≥ 6 months * Must speak English * Not pregnant * Fertile patients must use effective contraception * No moderately severe cognitive impairment * No schizophrenia or other psychosis * No disability claim currently being adjudicated for pain PRIOR CONCURRENT THERAPY: * See Disease Characteristics * Not in hospice care

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (17)

Community Cancer Center at Community Hospital of Anderson

Anderson, Indiana, 46011, United States

Location

Community Cancer Care at Bedford Oncology Specialty Clinic

Bedford, Indiana, 47421, United States

Location

Columbus Regional Hospital Cancer Center

Columbus, Indiana, 47201, United States

Location

Community Cancer Care at Putnam County Hospital

Greencastle, Indiana, 46135, United States

Location

Community Cancer Care at Decatur County Hospital

Greensburg, Indiana, 47240, United States

Location

Regenstrief Institute, Incorporated

Indianapolis, Indiana, 46202-2872, United States

Location

Community Cancer Care

Indianapolis, Indiana, 46202, United States

Location

Veterans Affairs Medical Center - Indianapolis

Indianapolis, Indiana, 46202, United States

Location

William N. Wishard Memorial Hospital

Indianapolis, Indiana, 46202, United States

Location

Methodist Cancer Center at Methodist Hospital

Indianapolis, Indiana, 46206-1367, United States

Location

Community Regional Cancer Care at Community Hospital East

Indianapolis, Indiana, 46219, United States

Location

Community Regional Cancer Care at Community Hospital North

Indianapolis, Indiana, 46256, United States

Location

Community Cancer Care at Howard Regional Health System

Kokomo, Indiana, 46902, United States

Location

Community Cancer Care at King's Daughters' Hospital

Madison, Indiana, 47250, United States

Location

Schneck Medical Center

Seymour, Indiana, 47274, United States

Location

Community Cancer Care at Perry County Hospital

Tell City, Indiana, 47586, United States

Location

Community Cancer Care at Tipton County Memorial Hospital

Tipton, Indiana, 46072, United States

Location

Related Publications (10)

  • Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology. 2010 Jul;19(7):734-41. doi: 10.1002/pon.1627.

  • Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, Tu W. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010 Jul 14;304(2):163-71. doi: 10.1001/jama.2010.944.

  • Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med. 2010 Oct 11;170(18):1686-94. doi: 10.1001/archinternmed.2010.337.

  • He A, Kroenke K, Stump T, Monahan PO, Connors J, Chernyak Y, Musey P. The patient health questionnaire somatization-anxiety-depression scale: Validation of the PHQ-SAD in 4 clinical trials. J Affect Disord. 2026 Apr 1;398:120906. doi: 10.1016/j.jad.2025.120906. Epub 2025 Dec 21.

  • Cohee AA, Kroenke K, Vachon E, Wu J, Tu W, Johns SA. Predictors of depression outcomes in adults with cancer: A 12 month longitudinal study. J Psychosom Res. 2020 Sep;136:110169. doi: 10.1016/j.jpsychores.2020.110169. Epub 2020 Jun 11.

  • Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, Monahan PO. Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials. Psychosom Med. 2016 Jul-Aug;78(6):716-27. doi: 10.1097/PSY.0000000000000322.

  • Choi Yoo SJ, Nyman JA, Cheville AL, Kroenke K. Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial. Gen Hosp Psychiatry. 2014 Nov-Dec;36(6):599-606. doi: 10.1016/j.genhosppsych.2014.07.004. Epub 2014 Jul 19.

  • Hayano J, Carney RM, Watanabe E, Kawai K, Kodama I, Stein PK, Watkins LL, Freedland KE, Blumenthal JA. Interactive associations of depression and sleep apnea with adverse clinical outcomes after acute myocardial infarction. Psychosom Med. 2012 Oct;74(8):832-9. doi: 10.1097/PSY.0b013e31826d2c81. Epub 2012 Sep 28.

  • Wang HL, Kroenke K, Wu J, Tu W, Theobald D, Rawl SM. Predictors of cancer-related pain improvement over time. Psychosom Med. 2012 Jul-Aug;74(6):642-7. doi: 10.1097/PSY.0b013e3182590904. Epub 2012 Jun 28.

  • Dube P, Kurt K, Bair MJ, Theobald D, Williams LS. The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Prim Care Companion J Clin Psychiatry. 2010;12(6):PCC.10m00978. doi: 10.4088/PCC.10m00978blu.

MeSH Terms

Conditions

DepressionPain

Interventions

AnalgesiaPsychiatric Rehabilitation

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia and AnalgesiaRehabilitationTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Kurt Kroenke, MD

    Regenstrief Institute, Incorporated

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 11, 2006

First Posted

April 12, 2006

Study Start

February 1, 2006

Primary Completion

January 1, 2010

Last Updated

September 20, 2013

Record last verified: 2009-05

Locations